Protalix BioTherapeutics (PLX) Shares Outstanding (2016 - 2024)
Historic Shares Outstanding for Protalix BioTherapeutics (PLX) over the last 16 years, with Q3 2024 value amounting to $73.6 million.
- Protalix BioTherapeutics' Shares Outstanding rose 93.41% to $73.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $73.6 million, marking a year-over-year increase of 93.41%. This contributed to the annual value of $73.0 million for FY2023, which is 3562.35% up from last year.
- According to the latest figures from Q3 2024, Protalix BioTherapeutics' Shares Outstanding is $73.6 million, which was up 93.41% from $73.3 million recorded in Q2 2024.
- In the past 5 years, Protalix BioTherapeutics' Shares Outstanding registered a high of $73.6 million during Q3 2024, and its lowest value of $32.4 million during Q1 2020.
- In the last 5 years, Protalix BioTherapeutics' Shares Outstanding had a median value of $48.7 million in 2022 and averaged $53.3 million.
- In the last 5 years, Protalix BioTherapeutics' Shares Outstanding skyrocketed by 13429.56% in 2020 and then skyrocketed by 93.41% in 2024.
- Over the past 5 years, Protalix BioTherapeutics' Shares Outstanding (Quarter) stood at $34.8 million in 2020, then surged by 31.04% to $45.6 million in 2021, then increased by 18.07% to $53.8 million in 2022, then surged by 35.62% to $73.0 million in 2023, then grew by 0.93% to $73.6 million in 2024.
- Its last three reported values are $73.6 million in Q3 2024, $73.3 million for Q2 2024, and $73.1 million during Q1 2024.